The condensin complex has been suggested as a potential therapeutic target for cancer [139], and human homologs YCG1/NCAPG2, YCS4/NCAPD2, and SMC4/SMC4 are synthetic lethal with the Ras oncogene [123]. The gene discussed is NCAPG2; the disease is cancer.